Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.
Clinical trial NCT04276480 · COMPLETED
Trial details
- NCT number
- NCT04276480
- Sponsor
- University Hospital, Bordeaux
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-16
- Primary completion
- 2024-04-22
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.